Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment option in both adult and pediatric patients with malignant and non-malignant hematological diseases. Chimerism analysis, which determines the donor or recipient origin of hematopoietic cells in HSCT recipients, is an essential aspect of post-HSCT follow-up. OBJECTIVES: To review the current literature and develop Belgian consensus guidelines for the use of chimerism analysis in the standard of care after allogeneic HSCT. METHODS: Non-systematic review of the literature in consultancy with the members... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Verlag/Hrsg.: |
Taylor & Francis
|
Schlagwörter: | Allogeneic stem cell transplantation / chimerism / graft failure / minimal residual disease |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26529954 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/230917 |